Coenzyme Q0 (Cat.#:AYB26736)
Cat.#:AYB26736
| Size | Price | |
|---|---|---|
| Free Sample (0.1 - 0.2 mg) | Inquiry | |
| 1 g | Inquiry | |
| 5 g | Inquiry | |
| 500 mg | ¥350.00 | Add to cart |
| 10 mM * 1 mL in DMSO | ¥385.00 | Add to cart |
Biological activity
Information
Biological activity
| Bioactivity | Coenzyme Q0 (CoQ0) is a potent, oral active ubiquinone compound can be derived from Antrodia cinnamomea. Coenzyme Q0 induces apoptosis and autophagy, suppresses of HER-2/AKT/mTOR signaling to potentiate the apoptosis and autophagy mechanisms. Coenzyme Q0 regulates NFκB/AP-1 activation and enhances Nrf2 stabilization in attenuation of inflammation and redox imbalance. Coenzyme Q0 has anti-angiogenic activity through downregulation of MMP-9/NF-κB and upregulation of HO-1 signaling. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| CAS | 605-94-7 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Mol.Wt. | 182.18 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| In vitro | Coenzyme Q0 (0-40 µM; 24 h) and inhibits viability and growth of human ovarian carcinoma cells. The accuracy of these methods have not been independently confirmed. They are for reference only. Cell Viability Assay
Cell Cycle Analysis
Apoptosis Analysis
Apoptosis Analysis
Western Blot Analysis
Western Blot Analysis
Western Blot Analysis
Western Blot Analysis
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Format | Solid | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Transportation | Room temperature in continental US; may vary elsewhere. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Solubility | In Vitro: DMSO : 50 mg/mL (274.45 mM; Need ultrasonic) 配制储备液
* 请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液;一旦配成溶液,请分装保存,避免反复冻融造成的产品失效。 In Vivo: 请根据您的实验动物和给药方式选择适当的溶解方案。以下溶解方案都请先按照 In Vitro 方式配制澄清的储备液,再依次添加助溶剂:
——为保证实验结果的可靠性,澄清的储备液可以根据储存条件,适当保存;体内实验的工作液,建议您现用现配,当天使用;
以下溶剂前显示的百
*以上所有助溶剂都可在 MCE 网站选购。 |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Purity | ≥99.0% |
